Liven Pharmaceuticals Statistics
Total Valuation
PSX:LIVEN has a market cap or net worth of PKR 4.72 billion. The enterprise value is 4.76 billion.
Market Cap | 4.72B |
Enterprise Value | 4.76B |
Important Dates
The last earnings date was Friday, April 25, 2025.
Earnings Date | Apr 25, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
PSX:LIVEN has 93.04 million shares outstanding. The number of shares has increased by 366.13% in one year.
Current Share Class | n/a |
Shares Outstanding | 93.04M |
Shares Change (YoY) | +366.13% |
Shares Change (QoQ) | +47.56% |
Owned by Insiders (%) | 7.21% |
Owned by Institutions (%) | 4.46% |
Float | 85.98M |
Valuation Ratios
The trailing PE ratio is 26.68.
PE Ratio | 26.68 |
Forward PE | n/a |
PS Ratio | 39.09 |
PB Ratio | 5.27 |
P/TBV Ratio | 5.50 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 212.12, with an EV/FCF ratio of -19.49.
EV / Earnings | 44.16 |
EV / Sales | 39.41 |
EV / EBITDA | 212.12 |
EV / EBIT | n/a |
EV / FCF | -19.49 |
Financial Position
The company has a current ratio of 3.76, with a Debt / Equity ratio of 0.04.
Current Ratio | 3.76 |
Quick Ratio | 1.76 |
Debt / Equity | 0.04 |
Debt / EBITDA | 1.70 |
Debt / FCF | -0.16 |
Interest Coverage | -25.25 |
Financial Efficiency
Return on equity (ROE) is 28.18% and return on invested capital (ROIC) is -0.04%.
Return on Equity (ROE) | 28.18% |
Return on Assets (ROA) | -0.04% |
Return on Invested Capital (ROIC) | -0.04% |
Return on Capital Employed (ROCE) | -0.04% |
Revenue Per Employee | 40.26M |
Profits Per Employee | 35.93M |
Employee Count | 3 |
Asset Turnover | 0.22 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +369.47% in the last 52 weeks. The beta is -0.14, so PSX:LIVEN's price volatility has been lower than the market average.
Beta (5Y) | -0.14 |
52-Week Price Change | +369.47% |
50-Day Moving Average | 86.19 |
200-Day Moving Average | 71.82 |
Relative Strength Index (RSI) | 12.98 |
Average Volume (20 Days) | 20,605 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PSX:LIVEN had revenue of PKR 120.79 million and earned 107.80 million in profits. Earnings per share was 1.90.
Revenue | 120.79M |
Gross Profit | 38.03M |
Operating Income | -364,503 |
Pretax Income | 118.92M |
Net Income | 107.80M |
EBITDA | 22.44M |
EBIT | -364,503 |
Earnings Per Share (EPS) | 1.90 |
Balance Sheet
The company has 93,283 in cash and 38.14 million in debt, giving a net cash position of -38.05 million or -0.41 per share.
Cash & Cash Equivalents | 93,283 |
Total Debt | 38.14M |
Net Cash | -38.05M |
Net Cash Per Share | -0.41 |
Equity (Book Value) | 895.91M |
Book Value Per Share | 9.63 |
Working Capital | 208.09M |
Cash Flow
In the last 12 months, operating cash flow was -230.29 million and capital expenditures -13.93 million, giving a free cash flow of -244.22 million.
Operating Cash Flow | -230.29M |
Capital Expenditures | -13.93M |
Free Cash Flow | -244.22M |
FCF Per Share | -2.62 |
Margins
Gross margin is 31.49%, with operating and profit margins of -0.30% and 89.24%.
Gross Margin | 31.49% |
Operating Margin | -0.30% |
Pretax Margin | 98.45% |
Profit Margin | 89.24% |
EBITDA Margin | 18.58% |
EBIT Margin | -0.30% |
FCF Margin | n/a |
Dividends & Yields
PSX:LIVEN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -366.13% |
Shareholder Yield | -366.13% |
Earnings Yield | 2.28% |
FCF Yield | -5.17% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
PSX:LIVEN has an Altman Z-Score of 17.42.
Altman Z-Score | 17.42 |
Piotroski F-Score | n/a |